Literature DB >> 12853886

Cisplatin-induced encephalopathy and seizures.

N Steeghs1, F E de Jongh, P A E Sillevis Smitt, M J van den Bent.   

Abstract

Cisplatin induces mainly a peripheral sensory neuropathy, but occasionally may also induce an encephalopathy with or without seizures. We describe the clinical signs and symptoms of cisplatin encephalopathy. The clinical events in three patients that developed seizures and encephalopathy with focal signs are described. Two patients completely recovered, one patient developed a focal status epilepticus, refractory to antiepileptic treatment, and died due to ongoing seizures. Post-mortem examination of the central nervous system in this patient showed an ischemic lesion in the left temporal area and mild gliosis of the white matter. One patient was rechallenged with cisplatin after which he developed a second episode of encephalopathy. We conclude that physicians using cisplatin chemotherapy should be aware of this rare complication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853886     DOI: 10.1097/00001813-200307000-00009

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  15 in total

1.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

Review 2.  [Acute central nervous symptoms in oncologic patients].

Authors:  K Orlopp; I G H Schmidt-Wolf; H Urbach; U Schlegel
Journal:  Internist (Berl)       Date:  2005-01       Impact factor: 0.743

3.  [Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil].

Authors:  F Paul; O Aktas; F-J Dieste; P Kreitsch; H-P Vogel; F Zipp
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

4.  Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine.

Authors:  Germán Morís; Renee Ribacoba; Carmen González
Journal:  J Neurol       Date:  2007-03-04       Impact factor: 4.849

Review 5.  [White matter alterations after chemotherapy and radiation].

Authors:  A Simgen
Journal:  Radiologe       Date:  2018-12       Impact factor: 0.635

Review 6.  Epilepsy in brain metastasis: an emerging entity.

Authors:  Roberta Rudà; Francesca Mo; Alessia Pellerino
Journal:  Curr Treat Options Neurol       Date:  2020-02-08       Impact factor: 3.598

Review 7.  Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment.

Authors:  Gagandeep Singh; Jeremy H Rees; Josemir W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

Review 8.  Cisplatin overdose: toxicities and management.

Authors:  Roger Y Tsang; Turki Al-Fayea; Heather-Jane Au
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Chemotherapy related encephalopathy in a patient with Stage IV cervical carcinoma treated with cisplatin and 5-fluorouracil: a case report.

Authors:  Amy L Chue; Indrajit N Fernando; Syed A Hussain; David A Yates
Journal:  Cases J       Date:  2009-07-30

10.  A case of Wernicke's encephalopathy following fluorouracil-based chemotherapy.

Authors:  In Jeong Cho; Hye Jung Chang; Kyoung Eun Lee; Hye Sung Won; Moon Young Choi; Eun Mi Nam; Yeung-Chul Mun; Soon Nam Lee; Chu-Myong Seong
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.